BridgeBio Pharma (BBIO) Q2 2025 Earnings Report

1,528 Followers

BBIO Q2 2025 EPS Results

Actual EPS-$0.95

Consensus EPS-$0.79

Beat/MissMissed by -$0.16

One Year Ago EPS-$0.39

Actual Revenue$110.56M

Expected Revenue$87.98M

Beat/MissBeat by +$22.58M

YoY Revenue Growth+4999.86%

QuarterQ2 2025

Date08/05/2025

TimeAfter Close

Conference CallTuesday, August 5, 2025

BBIO Upcoming Earnings

BridgeBio Pharma's next earnings date is estimated for October 29, 2026, based on past reporting schedules.

BBIO Q2 2025 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 29, 2026	2026 (Q3)	-0.61 / -	-0.95	―
Aug 10, 2026	2026 (Q2)	-0.58 / -0.78	-0.95	17.89% (+0.17)
May 07, 2026	2026 (Q1)	-0.68 / -0.84	-0.88	4.55% (+0.04)
Feb 24, 2026	2025 (Q4)	-0.71 / -1.00	-1.4	28.57% (+0.40)
Oct 29, 2025	2025 (Q3)	-0.89 / -0.95	-0.86	-10.47% (-0.09)
Aug 05, 2025	2025 (Q2)	-0.79 / -0.95	-0.39	-143.59% (-0.56)
Apr 29, 2025	2025 (Q1)	-0.92 / -0.88	-0.2	-340.00% (-0.68)
Feb 20, 2025	2024 (Q4)	-1.12 / -1.40	-0.96	-45.83% (-0.44)
Nov 12, 2024	2024 (Q3)	-1.00 / -0.86	-1.08	20.37% (+0.22)
Aug 01, 2024	2024 (Q2)	-1.00 / -0.39	-0.98	60.20% (+0.59)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed